POTENTIAL ANTI-PARKINSON DRUGS DESIGNED BY RECEPTOR MAPPING

被引：18

作者：

MARTIN, YC ^{[1
]}

JARBOE, CH ^{[1
]}

KRAUSE, RA ^{[1
]}

LYNN, KR ^{[1
]}

DUNNIGAN, D ^{[1
]}

HOLLAND, JB ^{[1
]}

机构：

[1] ABBOTT LABS,EXPTL THERAPY DIV,N CHICAGO,IL 60064

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1973年 / 16卷 / 02期

关键词：

D O I：

10.1021/jm00260a014

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：147 / 150

页数：4

共 21 条

[1]

ABOOD LG, 1968, DRUGS AFFECTING CENT, V2, P128

[2]

ABOOD LG, 1968, DRUGS AFFECTING CENT, V2, P158

[3]

BUSTARD T, 1971, TETRAHEDRON, V27, P44

[4]

CHO AK, 1962, J PHARMACOL EXP THER, V138, P249

[5] AROMATIC AMINO ACIDS AND MODIFICATION OF PARKINSONISM [J].

COTZIAS, GC ;

VANWOERT, MH ;

SCHIFFER, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (07) :374-&

[6] ANTIPARKINSONIAN DRUGS - INHIBITION OF DOPAMINE UPTAKE IN CORPUS STRIATUM AS A POSSIBLE MECHANISM OF ACTION [J].

COYLE, JT ;

SNYDER, SH .

SCIENCE, 1969, 166 (3907) :899-+

[7]

EVERETT GM, 1966, PHARMACOLOGIST, V8, P184

[8] PHARMACOLOGICAL ASPECTS OF PARKINSONISM [J].

FRIEDMAN, AH ;

EVERETT, GM .

ADVANCES IN PHARMACOLOGY, 1964, 3 :83-127

[9]

GOLDSTEIN M, 1970, FED P FED AM SOC EXP, V29, P280

[10]

GOODMAN LS, 1953, PHARMACOLOGICAL BASI, P473

← 1 2 3 →